Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
19/05/2025
Spot gold has just broken through the $3230.00 per ounce mark, currently trading at $3230.20 per ounce, up 0.91% intraday; COMEX gold futures are trading at $3231.90 per ounce, up 1.40% intraday.
Latest
2 m ago
Ningbo Shipping (600798.SH): The company's latest trailing P/E ratio of 20706.36 is significantly higher than the industry average.
2 m ago
Due to heavy rain, some conventional speed trains in Shenzhen were suspended on May 19th.
3 m ago
Tonight, the price of oil will be lowered: topping up a full tank of gas will save you 9 yuan.
3 m ago
On May 16, a signing ceremony was held in the Suzhou Industrial Park for the renewal of the partnership agreement between China National Pharmaceutical Group and the Swiss Lonza Group to establish Suzhou Capsule Co., Ltd. for another twenty years. Jean-Christophe Hyvert, President of the Capsules and Nutritional Ingredients Division of Lonza Group, expressed his anticipation for the continued collaboration between Lonza Group and China National Pharmaceutical Group to better serve global patients in the next twenty years. Lonza Group will also continue to increase its investment in China, introducing new products and technologies to promote the development of the joint venture company.
3 m ago
China National Pharmaceutical Group and Longsha Group signed a joint venture extension agreement for Suzhou Capsule Co., Ltd.
See all latest